Preliminary characteristic of 45 patient of the study placebo-controlled, randomized, double-blind clinical trial to assess the safety and efficacy of using Deep Transcranial Magnetic Stimulation (EMTp) in smoking cessation.

• B. Bellini,
• J.R. Scholz,
• D. Arnaut,
• T.M.O. Abe,
• R.L. Alberto,
• C.L. Ferrari,
• A.F. Jafet,
• M.J. Teixeira,
• M.A. Marcolin

Affiliations

B. Bellini

Incor (Heart Institute): Smoking Cessation Program, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil; Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil; Corresponding author.

J.R. Scholz

Incor (Heart Institute): Smoking Cessation Program, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil

D. Arnaut

Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil

T.M.O. Abe

Incor (Heart Institute): Smoking Cessation Program, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil

R.L. Alberto

Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil

C.L. Ferrari

Incor (Heart Institute): Smoking Cessation Program, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil

A.F. Jafet

Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil

M.J. Teixeira

Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil

M.A. Marcolin

Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil